Literature DB >> 23390057

Avoiding idiosyncratic DILI: two is better than one.

Neil Kaplowitz.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23390057     DOI： 10.1002/hep.26295

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  18 in total

1.  A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.

Authors:  Minjun Chen; Chun-Wei Tung; Qiang Shi; Lei Guo; Leming Shi; Hong Fang; Jürgen Borlak; Weida Tong
Journal:  Arch Toxicol       Date:  2014-06-11       Impact factor: 5.153

Review 2.  Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications.

Authors:  Lily Dara; Zhang-Xu Liu; Neil Kaplowitz
Journal:  Liver Int       Date:  2015-11-11       Impact factor: 5.828

Review 3.  Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.

Authors:  Robert J Fontana
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

4.  Evaluation of the Relevance of DILI Predictive Hypotheses in Early Drug Development: Review of In Vitro Methodologies vs BDDCS Classification.

Authors:  Rosa Chan; Leslie Z Benet
Journal:  Toxicol Res (Camb)       Date:  2018-04-18       Impact factor: 3.524

5.  Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.

Authors:  Shuji Sumie; Takumi Kawaguchi; Atsushi Kawaguchi; Ryoko Kuromatsu; Masahito Nakano; Manabu Satani; Shingo Yamada; Shusuke Okamura; Yuko Yonezawa; Tatsuyuki Kakuma; Takuji Torimura; Michio Sata
Journal:  Mol Clin Oncol       Date:  2014-10-06

6.  Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

Authors:  Raj Vuppalanchi; Raghavender Gotur; K Rajender Reddy; Robert J Fontana; Marwan Ghabril; Andrzej S Kosinski; Jiezhun Gu; Jose Serrano; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-20       Impact factor: 11.382

7.  Modeling the Bioactivation and Subsequent Reactivity of Drugs.

Authors:  Tyler B Hughes; Noah Flynn; Na Le Dang; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2021-01-26       Impact factor: 3.739

Review 8.  Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.

Authors:  Rolf Teschke; Jack Uetrecht
Journal:  Ann Transl Med       Date:  2021-04

Review 9.  Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies.

Authors:  Rolf Teschke; Gaby Danan
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

10.  Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.

Authors:  Tyler B Hughes; Na Le Dang; Ayush Kumar; Noah R Flynn; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-09-16       Impact factor: 4.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.